Jas Lee Image

Jas Lee

Shareholder

Wolf Greenfield

Jas Lee is a Shareholder with Wolf Greenfield. Jas works with clients in IP strategy development and execution, including IP portfolio management, US and foreign patent prosecution, non-infringement and invalidity opinions, and due diligence. She counsels a variety of clients including start-up companies, large global corporations, venture capital firms, and academic institutions on US and international patent issues.

Jas has a broad technical background including experience in the areas of microfluidics, medical devices and diagnostics, drug delivery, bioreactors, cleantech technologies, electrochemical devices (lithium batteries), nanotechnology, microfabrication, materials chemistry, organic chemistry, and pharmaceuticals.

Jas particularly enjoys helping start-up companies identify their most valuable IP and best strategies to protect them. She has served as a judge for the MIT $100K competition for several years. She has also been a guest lecturer at an entrepreneurship class at Harvard.

Jas performed her doctoral work under the supervision of Professor George Whitesides at Harvard University. Her doctoral thesis focused on the design, fabrication, and testing of integrated microfluidic systems for chemical and biochemical assays using soft-lithography. She also studied the compatibility of mammalian cells on polymer surfaces and self-assembling systems in fluids.

Jas serves as chair of Wolf Greenfield’s Diversity Committee.

Recent Articles by Jas Lee

Public-Use Bar: What Startups Need to Know

Startups often face many competing pressures. Two such pressures that are frequently at odds with each other are the need to adequately protect the intellectual property that will be the basis for future revenue and investment, and the need to bring such revenue and investment into the business to allow for continued technology development and commercialization. Many startups are aware of how the on-sale bar interacts with these pressures and the associated need to file patent applications on any technology prior to offering or placing it on sale. However, fewer startups are aware of the public-use bar and how activities pursued with the goal of growing their businesses may unwittingly invoke it.